Company profile for Apimeds Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammation and pain. Founded in 2020 and headquartered in Hopewell, New Jersey, we specialize in researching, developing, and commercializing Apitox, our proprietary active pharmaceutical ingredient derived from purified bee venom. Our primary focus is on treating symptoms associated with osteoarthrit...
Apimeds Pharmaceuticals US, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for inflammation and pain. Founded in 2020 and headquartered in Hopewell, New Jersey, we specialize in researching, developing, and commercializing Apitox, our proprietary active pharmaceutical ingredient derived from purified bee venom. Our primary focus is on treating symptoms associated with osteoarthritis and multiple sclerosis. Apitox's unique anti-inflammatory and pain-relieving properties position it as a promising therapeutic candidate.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
25 Edinburg Circle Matawan, NJ 0774
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

euroPLX 90 Lisbon

Not Confirmed

envelop Contact Supplier

euroPLX 90 Lisbon

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251210901177/en/Apimeds-Pharmaceuticals-and-MindWave-Innovations-Announce-Closing-of-%24100MM-PIPE-Financing-and-Activation-of-1000-Bitcoin-to-Power-AI-Driven-Yield-Generation-Strategy

BUSINESSWIRE
10 Dec 2025

https://www.pharmiweb.com/press-release/2025-12-01/apimeds-and-mindwave-announce-merger-integrating-biotech-growth-with-ai-driven-digital-treasury-yie

PHARMIWEB
01 Dec 2025

https://www.businesswire.com/news/home/20251110665157/en/Apimeds-Brings-ai-Futures-Lab-to-the-Palouse-Partnering-with-the-University-of-Idaho-to-Shape-the-Future-of-Biotech-Innovation

BUSINESS WIRE
10 Nov 2025

https://www.pharmiweb.com/press-release/2025-10-14/apimeds-pharmaceuticals-says-i-love-my-ducks-with-new-ai-futures-lab-program-collaboration-with

PHARMIWEB
14 Oct 2025

https://www.businesswire.com/news/home/20250912177584/en/Apimeds-Expands-ai-Future-Labs-Program-to-Include-University-of-San-Diego-Students-in-Biotech-Business-Development

BUSINESSWIRE
15 Sep 2025

https://www.businesswire.com/news/home/20250911206702/en/Apimeds-Welcomes-FDA-Draft-Guidance-as-Catalyst-for-Advancing-Apitox-Non-Opioid-Pain-Program

BUSINESSWIRE
11 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty